Related Experiment Video
Updated: Apr 26, 2026

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
Proteus mirabilis and its role in dacryocystitis
1*OD, FAAO Southern College of Optometry, Memphis, Tennessee.
Purpose:
Dacryocystitis is a common inflammation of the lacrimal sac, usually from an underlying bacterial infection. Most cases can be attributed to common ocular flora such as Staphylococcus aureus or Streptococcus pneumoniae; however, uncommon bacterial causes such as Proteus mirabilis can still occur. P. mirabilis is a gram-negative bacillus that is found abundantly in people who have undergone long-term catheterization and is uncommonly found in or around the eyes except in people who have undergone long-term catheterization. Proteus species can cause conjunctivitis, canaliculitis, and dacryocystitis and have the ability to manifest into preseptal cellulitis; therefore, timely recognition and treatment are important to prevent potential further complications.
Case Report:
An 84-year-old white man had several recurrences of acute dacryocystitis that had marginal improvement with empiric antibiotic treatment. Resultant culture of the ocular discharge revealed an uncommon bacterium, P. mirabilis. Successful dosing of oral antibiotics resolved the infection but ultimately the patient required an external dacryocystorhinostomy (DCR) procedure to maintain patency of the nasolacrimal lacrimal system and prevent recurrence. At 3 months after external DCR, the patient was symptom free with no recurrences.
Conclusions:
Dacryocystitis has a distinctive clinical presentation and is usually easily treated when appropriate oral antibiotics are directed at the underlying pathogen. In nonresponsive cases, culturing of the ocular discharge should be performed to identify the underlying pathogen. Cases of dacryocystitis caused by Proteus species are usually responsive to several standard antibiotics used orally in eye care; however, culturing and susceptibility testing can streamline the diagnostic and management sequence considerably in unclear or unresponsive cases. Typically, patients with dacryocystitis return to normal after appropriate treatment, but chronic recurrences and epiphora are potential sequelae. Patients should be educated that a DCR surgical procedure may be needed to prevent future recurrences in some cases.
Insights
Dacryocystitis, an infection of the lacrimal sac, can rarely be caused by Proteus mirabilis. Prompt diagnosis and targeted antibiotics, potentially followed by dacryocystorhinostomy (DCR), are key for effective treatment and preventing recurrence.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Dacryocystitis, an inflammation of the lacrimal sac, is typically caused by common bacteria like Staphylococcus aureus.
- Uncommon pathogens, such as Proteus mirabilis, can also lead to dacryocystitis, especially in specific patient populations.
Observation:
- A case study involving an 84-year-old male with recurrent dacryocystitis unresponsive to empiric antibiotics.
- Ocular discharge culture identified Proteus mirabilis as the causative agent.
- Initial treatment with oral antibiotics showed partial success, but a dacryocystorhinostomy (DCR) was ultimately required.
Findings:
- Proteus mirabilis, a gram-negative bacillus, can cause ocular infections including dacryocystitis.
- Culture and susceptibility testing are crucial for identifying uncommon pathogens and guiding treatment in non-responsive dacryocystitis cases.
- While standard oral antibiotics can treat Proteus-induced dacryocystitis, surgical intervention like DCR may be necessary for long-term resolution and prevention of recurrence.
Implications:
- Highlights the importance of considering uncommon bacterial pathogens in refractory dacryocystitis.
- Emphasizes the role of microbiological cultures in guiding appropriate antibiotic therapy.
- Underscores that surgical management, such as DCR, may be essential for managing chronic or recurrent cases of dacryocystitis to restore nasolacrimal patency.
Related Concept Videos
Microbiome of the Eye
Diphtheria
Urinary Tract Infection II: Pathophysiology

